Lloyd R. Kelland

Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.

Lloyd R. Kelland, G Abel, Mark J. McKeage et al. · PubMed · 1993 · 224 citations

Medicine, Oncology, Pharmacology +7

Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.

Lloyd R. Kelland, Barry A. Murrer, G Abel et al. · PubMed · 1992 · 168 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines

Lloyd R. Kelland, G Abel · Cancer Chemotherapy and Pharmacology · 1992 · 138 citations

Medicine, Oncology, Pharmacology +12

Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.

Lloyd R. Kelland, Prakash Mistry, G Abel et al. · PubMed · 1992 · 124 citations

Medicine, Oncology, Pharmacology +16

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.

Lloyd R. Kelland, Prakash Mistry, G Abel et al. · PubMed · 1992 · 94 citations

Medicine, Oncology, Pharmacology +17